Two birds with one stone: dual p110δ and p110γ inhibition
- PMID: 24267274
- PMCID: PMC4523579
- DOI: 10.1016/j.chembiol.2013.11.002
Two birds with one stone: dual p110δ and p110γ inhibition
Abstract
In this issue of Chemistry & Biology, Winkler and colleagues describe the discovery and preclinical development of IPI-145, a new inhibitor of the phosphoinositide 3-kinase (PI3K) isoforms p110δ and p110γ that have entered clinical trials.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
Comment on
-
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.Chem Biol. 2013 Nov 21;20(11):1364-74. doi: 10.1016/j.chembiol.2013.09.017. Epub 2013 Nov 7. Chem Biol. 2013. PMID: 24211136
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
